Centivax, Inc.
CAGE Code: 8LXR4
NCAGE Code: 8LXR4
Status: Active
Type: Commercial Supplier
Summary
Centivax, Inc. is an Active Commercial Supplier with the Cage Code 8LXR4.
Address
1 Tower Pl Ste 800
South San Francisco CA 94080-1837
United States
Points of Contact
No Points of Contact...
Related Information
No Related Information...
People who viewed this 'CAGE Code' also viewed...
Edwards E H Co Cellular One O Brien Corp The Dba Fuller-O Brien Mascot Metropolitan Inc. Pacific Floor Machine Mfg Co Mcdowell And Co Pacific Basin Produce, Inc. Cellular One Fluid Gauge Co, Inc Matsushita Services Co Gko And Associates Suregrave Engraving Systems Inc Pioneer Motor Bearing Co. Microware Exceltek Inc Blue Ribbon Supply Co Api-Lirco Corp Athena Neurosciences Inc Aeroground, Inc Okada Supply Company Llc Concord Industries Inc
Frequently Asked Questions (FAQ) for CAGE 8LXR4
- What is CAGE Code 8LXR4?
- 8LXR4 is the unique identifier used by NATO Organizations to reference the physical entity known as Centivax, Inc. located at 1 Tower Pl Ste 800, South San Francisco CA 94080-1837, United States.
- Who is CAGE Code 8LXR4?
- 8LXR4 refers to Centivax, Inc. located at 1 Tower Pl Ste 800, South San Francisco CA 94080-1837, United States.
- Where is CAGE Code 8LXR4 Located?
- CAGE Code 8LXR4 is located in South San Francisco, CA, USA.
Contracting History for CAGE 8LXR4 Most Recent 25 Records
- W81XWH21P0024
- No-Cost Extension To The Award Of Centivax Dha Sbir Phase I Medical R&D Purchase Order For "Development Of Human Monoclonal Antibody Therapeutic Against Klebsiella Pneumoniae Infection"
- 23 Sep 2021
- No-Cost Extension To The Award Of Centivax Dha Sbir Phase I Medical R&D Purchase Order For "Development Of Human Monoclonal Antibody Therapeutic Against Klebsiella Pneumoniae Infection"
- W4pz Usa Med Rsch Acquis Act
- Department Of Defense (Dod)
- $249,938.69
- Department Of Defense (Dod)
- W81XWH21P0024
- Award Of Centivax's Dha Sbir Phase I Medical R&D Purchase Order For "Development Of Human Monoclonal Antibody Therapeutic Against Klebsiella Pneumoniae Infection"
- 7 Jan 2021
- Award Of Centivax's Dha Sbir Phase I Medical R&D Purchase Order For "Development Of Human Monoclonal Antibody Therapeutic Against Klebsiella Pneumoniae Infection"
- W4pz Usa Med Rsch Acquis Act
- Department Of Defense (Dod)
- $249,938.69
- Department Of Defense (Dod)